Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
Novartis Pharmaceuticals
Yen-Shen Lu; Eznal Izwadi Bin Mohd Mahidin; Hamdy Azim; Yesim Eralp; Yoon Sim Yap; Seock-Ah Im; Julie Rihani; Erhan Gokmen; Ahmed El Bastawisy; Nuri Karadurmus; Yueh Ni Lim; Chun Sen Lim; Le Thanh Duc; Wei-Pang Chung; K Govind Babu; Konstantin Penkov; James Bowles; Teresa Delgar Alfaro; Jiwen Wu; Melissa Gao; Khemaies Slimane; Nagi S El Saghir